According to the case study in the image,What does the SWOT Analysis tell us about the competitive position of Pharmcare with the industry as a whole?How readily do you think executives of Pharmcare identify the strengths and weaknesses of competitors?Identify the benefits and dangers (other than those identified in the text) of a SWOT Analysis such as that in the illustration. ILLUSTRATION 3.6(b) Competitor SWOT analysesSWOT analysis of PharmcareEnvironmental change (opportunities and threats)ILLUSTRATIONIncreased integration ofhealthcareComplex and changingbuying structuresInformed and passionatepatientsA SWOT analysis explores the relationship between the environmental influencesand the strategic capabilities of an organisation compared with its competitors.Healthcare rationingOverall impactPharmcare-346-3-2-2Struggling to provecost-effectiveness of newBig global playersuffering fall inshare price, lowresearch productivityand post-megamerger bureaucracyWell-known brand,a flexible sales forcedrugs to new regulators of combined with a newhealthcare educationdepartment createspositive synergyWeak ICT and lack ofintegration followingmergers means sales,research and admin. areall underperformingDecliningperformance overtime worsened aftermergerHave yet to get into thegroove of patient powerfuelled by the internet(a) SWOT analysis for Pharmcarehealthcare rationingEnvironmental change (opportunities and threats)Company WBig pharma withpatchy responseto change, losirngground in new areasof competition-4-440144Increasedintegration ofhealthcareNew recruits in the ICTdepartment have workedcross-functionally toinvolve patients ikenever beforeNeeds to moderniseacross the wholeFocus is on old-stylepromotional selling ratherthan helping doctorscontrol costs throughdrugsAlliances with equipmentmanufacturers but littleComplex andchanging buyingstructuresTraditional salesforce not helped byHealthcarerationingInformedpatientsmarketing which can be work done across allianceсоmpanyunaccommodating ofnational differencesto show dual use ofdrugs and new surgicaltechniques+StrengthsFlexible sales forceEconomies of scaleStrong brand nameHealthcare education department+3+5+2+3+2+3-1+512+63+2+3Patients will fight foradvances in treatmentOrganisation XPartnership betweena charity managedby people withventure capitalexperience and tophospital geneticists+3+2+10Could be the basisPotentially able todeliver rapid advances ingenetics-based illnessesAble possibly to bypassthese with innovativeInnovative drugs canhelp integrate healthcarethrough enabling patients areas where little recentto stay at homeof a new businessmodel for drugdiscovery - but all toprove as yet+2+1+3-1cost-effective drugts)+4+416progress has been madeWeaknessesLimited competences inbiotechnology and geneticsEver lower R&D productivityWeak ICT competencesOver-reliance on leading product-4-3-7Сompany YOnly develops drugsfor less commondiseases+3+2+1Freephone call centresfor sufferers of less+6-3-2-1-2-2-1Partnering with bigpharma allows thedevelopment of drugsdiscovered by big pharmabut not economical forthem to developFocus on small marketsegments so not asvulnerable to overallmarket structure, butinnovative approachmight be riskyInnovative use of web toshow why products stillworthwhile developingeven for less commonillnessesNovel approach canbe considered eitherrisky or a winner, orboth!-1-5-2-5-1-8-14-6common illnessesCompany, like patients,is passionate about itsmission-3Environmental impact scores+9-6+9-5+9-13+10-12Questions(b) Competitor SWOT analyses1 What does the SWOT analysis tell us about the competitive position of Pharmcare with the industryas a whole?2 How readily do you think executives of Pharmcare identify the strengths and weaknesses of competitors?3 Identify the benefits and dangers (other than those identified in the text) of a SWOT analysis such asthat in the illustration.

Question

Accepted Answer

SWOT analysis (or SWOT matrix) is a strategic planning technique utilizes to assist an individual or…